KYOWA KIRIN, INC

Lobbying for KYOWA KIRIN, INC · Pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $190,000.00 expenses · posted Jan 20, 2026

Lobbying activity 2

Pharmacy

Trade/tariffs and pharmaceutical pricing/value

Trade (domestic/foreign)

Tariffs and trade policy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem